Thomas Sandal

Title: Thomas Sandal: Innovator in Modified Proteins and Peptides

Introduction

Thomas Sandal is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of biochemistry, particularly in the development of modified proteins and peptides. His innovative work has led to advancements that may have important implications in various medical applications.

Latest Patents

Thomas Sandal holds a patent for "Modified proteins and peptides." This patent describes modified proteins and peptides that have a reduced ability to bind to pre-existing antibodies. The modified molecules can include C-terminal additions, extensions, or tags, as well as specific amino acid substitutions. These innovations encompass proteins, peptides, antigen-binding molecules, antibodies, or antibody fragments, such as single variable domains. The patent also covers the uses and formulations of compositions that include these modified molecules, along with methods for their production and expression.

Career Highlights

Sandal is associated with Glaxo Group Limited, where he has been able to apply his expertise in biochemistry to develop groundbreaking solutions. His work has contributed to the advancement of therapeutic options in the pharmaceutical industry. With a focus on innovative protein engineering, he has positioned himself as a key player in his field.

Collaborations

Throughout his career, Thomas Sandal has collaborated with talented individuals such as Claire Ashman and Mary Birchler. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions.

Conclusion

In summary, Thomas Sandal is a distinguished inventor whose work in modified proteins and peptides has the potential to impact the medical field significantly. His contributions, along with his collaborations, highlight the importance of innovation in advancing biochemistry and therapeutic applications.